Skip to site menu Skip to page content

Daily Newsletter

22 August 2023

Daily Newsletter

22 August 2023

Swire Pacific in talks to acquire stake in Indonesian healthcare group

Pertamedika IHC could be valued at around $450m to $650m in the deal, people privy to the development told the publication.

August 21 2023

Diversified global group Swire Pacific is in advanced discussions to acquire a minority interest in Indonesian state-owned hospital operator Pertamina Bina Medika IHC, reported Bloomberg.

The deal is said to be part of Hong Kong-listed Swire's strategy to identify new avenues of growth in sectors including healthcare and sustainable foods.

It could offer Pertamedika IHC a valuation of nearly $450-650m, the publication stated citing people privy to the development.

The negotiations are still in progress, and there is no certainty of a transaction materialising from the talks.

A deal, if reached, may conclude by the end of the year, added the unnamed people.

There was no official  confirmation of the development by the companies involved.

Pertamedika IHC operates 36 hospitals as well as 172 health clinics in Indonesia, with its first hospital established in 1967 for staff of state-run conglomerate PT Pertamina.

In March, Pertamina IHC and Asuransi Jiwa Inhealth Indonesia (Mandiri Inhealth) teamed up to enhance access to health services for the community.

The partnership was aimed at bolstering national health security by delivering healthcare services through IHC's network of hospitals and clinics.

In recent times, consolidation activities in the healthcare sector have been on the rise in Southeast Asia.

This includes the purchase of Vietnam’s FV Hospital by Thomson Medical Group last month in a deal worth up to $381.4m.  

Generative AI set to transform the medical devices industry

GlobalData estimates the total AI market will be worth $908.7 billion in 2030, with a 35% CAGR (2022-30). Generative AI can improve personalized healthcare by collecting data from patients via wearable devices. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data and information through AI medical products could conflict with regulations around the globe.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close